Profit

Prefer Dishman Among Midcap Pharma Stocks: Angel Broking

PUBLISHED ON: April 1, 2015 | Duration: 12 min, 46 sec

  
loading..
Mayuresh Joshi of Angel Broking says that Dishman Pharmaceuticals' Ebitda margins are expected to improve from the first quarter of FY16 on the back of commercial orders being executed.
ALSO WATCH
Record Run For Markets: What Does It Mean For You?

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com